SCHEMBL6466625

SCHEMBL6466625

O=C(CSC(=S)N(Cc1ccccc1)Cc1ccccc1)Nc1ccc(Cl)cc1Cl

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.67
▸ LMNA P02545 6/20 0.67
▸ HPGD P15428 1/20 0.67
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ ALOX12 P18054 1/20 0.48
▸ CACNA1G O43497 1/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.46
▸ HTT P42858 1/20 0.45
▸ POLB P06746 2/20 0.44
▸ GAA P10253 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ OPRK1 P41145 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6461787 0.85 ALDH1A1 (0.47) ALDH1A1LMNAHPGDNPC1RAB9A
SCHEMBL6460154 0.80 TP53 (0.54) ALDH1A1LMNAL3MBTL1MEN1KMT2A
SCHEMBL11148177 0.79 ALDH1A1 (0.63) ALDH1A1LMNANPC1RAB9AL3MBTL1
SCHEMBL6466633 0.77 ALDH1A1 (0.55) ALDH1A1LMNAHPGDNPC1RAB9A
SCHEMBL6468205 0.74 KMT2A (0.52) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL10885570 0.71 ALDH1A1 (0.57) ALDH1A1NPC1RAB9AL3MBTL1CACNA1G
SCHEMBL6465990 0.71 LMNA (0.60) ALDH1A1LMNAL3MBTL1MEN1KMT2A
SCHEMBL25658442 0.71 ALDH1A1 (0.62) ALDH1A1LMNAHPGDNPC1RAB9A
SCHEMBL497131 0.69 POLB (0.72) ALDH1A1LMNAHPGDNPC1RAB9A
SCHEMBL9313409 0.69 MEN1 (0.67) ALDH1A1HPGDNPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005090299-A2 CARBAMATES AS HIV ANTI-VIRAL AGENTS WYETH (US) 2005-09-29 — — WO claimed
US-20050203176-A1 Carbamates as HIV anti-viral agents WYETH (US) 2005-09-15 — — US claimed
WO-2005090299-A2 CARBAMATES AS HIV ANTI-VIRAL AGENTS WYETH (US) 2005-09-29 — — WO disclosed
US-20050203176-A1 Carbamates as HIV anti-viral agents WYETH (US) 2005-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203176-A1 Carbamates as HIV anti-viral agents RNASEH1, CTSH, RNASE1 ALDH1A1 2591/4885LMNA 2574/4885HPGD 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback